Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Self Storage Group ASA: Invitation to presentation of Q3 2020 results

Self Storage Group ASA (Self Storage Group, OSE:SSG) will release its financial results for third quarter 2020 on Tuesday 3 November 2020. The results will be presented at 08:00 (CET) at Felix Conference Centre, Bryggetorget 3, Oslo, Norway. The presentation will be held by CEO Fabian Søbak and CFO Cecilie Brænd Hekneby. The presentation will be held in English. The presentation will be broadcasted live on https://www.selfstoragegroup.no/web-cast/ If you would like to attend the presentation, please register by email to cehe@selfstoragegroup.no. Due to Covid-19 restrictions, we are

Three Guardian News & Media titles added to Readly’s growing portfolio

Readly , the European category leader in digital magazines, continues to bolster its portfolio of national dailies and magazines. Guardian News & Media has added The Guardian, The Observer and its international news magazine Guardian Weekly to the platform, expanding their global reach to Readly’s subscribers and gaining access to data insights generated by the all-you-can-read service.Two of the UK’s leading publishers, the ESI Media and Reach plc, joined Readly earlier this year making six national news titles available for the Readly global audience. The addition

Swedish Stirling approved for listing on Nasdaq

Swedish Stirling AB has been approved for listing on the Nasdaq First North Premier Growth Market. The first day off trading will be 6 November, 2020.Clean tech company Swedish Stirling has been approved by Nasdaq First North for listing on the Nasdaq First North Premier Growth Market. The first trading day will be 6 November, 2020. The company will be delisted from NGM Nordic SME and the last trading day will be 5 November, 2020. Shareholders in Swedish Stirling do not need to take any measures due to the change of listing venue.

Hansa Biopharma Nomination Committee formed

Lund November 2, 2020. Hansa Biopharma today announced that the Nomination Committee has been formed in accordance with the principles adopted by the Annual General Meeting (AGM) on June 23, 2020 and has the following composition:•    Natalie Berner representing Redmile Group •    Thomas Olausson  •    Jannis Kitsakis representing AP4•    Ulf Wiinberg, Chairman of the Board  The Chairman of the Board shall also summon the first meeting of the Nomination Committee.The function of the Nomination Committee is to prepare and submit proposals for the AGM regarding the number of

Changes in Gunnebo’s Group Executive Team

Robert Hermans has chosen to resign from his role as Vice President for Gunnebo and SVP for Business Unit Entrance Control to take on new challenges outside our industry.“I would like to thank Robert for his performance and many years of commitment to Gunnebo, which has positioned Entrance Control as a world-leading player in its field. In addition, on behalf of the Group Executive Team, I would like to wish Robert the best of success in his new role,” says Stefan Syrén, President and CEO of Gunnebo. Robert Hermans will remain in office during his notice period and will after that take

Vicore strengthens its pipeline with the acquisition of novel AT2R agonists and decides on an issue in kind of 142,054 shares

Gothenburg, November 2, 2020 – Vicore Pharma Holding AB (publ) (“Vicore”), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announces the acquisition of a series of intellectual property rights (IPR) as part of the development of novel angiotensin II type 2 receptor (AT2R) agonists.Vicore, which is developing first-in-class orally available small molecule angiotensin II type 2 receptor (AT2R) agonists, today announces the acquisition of IPR that collectively constitutes a pipeline of novel preclinical-stage AT2R agonists from HaLaCore

Peutinger AB increases the price in the offer to the shareholders of Internationella Engelska Skolan to SEK 82 per share and extends the acceptance period

THIS PRESS RELEASE IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED BY APPLICABLE LAW. SHAREHOLDERS NOT RESIDENT IN SWEDEN WHO WISH TO ACCEPT THE OFFER (AS DEFINED BELOW) MUST MAKE INQUIRIES CONCERNING APPLICABLE LEGISLATION AND POSSIBLE TAX CONSEQUENCES. SHAREHOLDERS SHOULD REFER TO THE OFFER RESTRICTIONS INCLUDED IN THE SECTION TITLED “IMPORTANT INFORMATION” AT THE END OF THIS

Many cities lack climate adaptation plans

Only one in four European cities have any adaptation plan for coming climate changes. There is still time to act – but we urgently need to raise the pace.The worst flooding disaster in more than 100 years recently hit southern France and northern Italy, with the French coastal city of Nice as one of those hit the worst. Extreme climate-related weather events in our cities are expected to occur with increasing frequency and size during the coming decades.  Today, however, only 26 percent of Europe’s cities have any adaptation plan for coming climate changes. And among these cities, most

Read original

Implantica files pre-submission with FDA for RefluxStop™

Implantica AG (publ) today announced it has completed a pre-submission to the U.S. Food and Drug Administration (FDA) for RefluxStop™, a CE-marked medical implant for the prevention of gastroesophageal reflux disease (GERD).Implantica expects to receive an initial meeting with the FDA within 75-90 days of the pre-submission filing date, at which point the company will have a better understanding of the path forward for FDA approval. “Our pre-submission is the next step in terms of FDA approval for RefluxStop™ which has the potential to totally change acid reflux treatment.

Adapteo Q3: Resilient sales and earnings

Adapteo Plc Regulatory press release 2 November 2020 at 7:30 a.m. CET July-September 2020 · Rental sales amounted to EUR 32.7 (31.8 in July-September 2019) million, an increase by 3% in constant currencies.  · Net sales amounted to EUR 59.1 (60.1) million. In constant currencies, net sales decreased by 1%.  · Comparable EBITDA was EUR 21.9 (23.1) million, down by 5%. Comparable EBITDA margin was 37.0% (38.4%).  · Operating cash flow before growth capex was EUR 11.5 (0.5) million.  · Growth capex was EUR 10.5 (2.5) million.  Comments from the CEO In the

Arjo presents updated strategy for continued profitable growth

Arjo’s updated strategy and new financial targets for 2021-2023 will be presented today at the Group’s Capital Markets Day. With the new strategy, Arjo is taking an important step in offering outcome-based solutions for healthcare, while focusing on enhancing efficiency. The financial targets include annual organic growth of 3-5% combined with an adjusted EBITDA margin of approximately 23% toward the end of the period, and annual cash conversion of more than 80%. “Since our listing three years ago, we have built a solid foundation and taken Arjo back to profitable growth. Now we are

Nyfosa acquires retail property portfolio at a value of MSEK 175

Nyfosa has acquired a portfolio comprising of seven retail properties in the big box retail area Bråstorp in Motala at a total value of approximately MSEK 175. The acquisition contributes with strong tenants and stable cash flows.The properties comprise an area of approximately 17 thousand square meters with a rental value of approximately MSEK 17. The portfolio is situated in the big box retail area Bråstorp just outside Motala with several established companies as tenants. The largest tenants include Rusta, Jysk, ÖoB, Swedol and Dollarstore. The economic occupancy rate is 93 percent.

Zutec today released Q1-21 report: Break-through Quarter with 47.2% Organic Growth and 19.4% EBITDA Margin

Financial Highlights · Net sales was SEK 10.1m, corresponding to a 47.2% increase compared with the same period in 2019 (SEK 6.8m). Reaching SEK 10m in quarterly sales was a significant milestone. · EBITDA of SEK 2.0m (SEK -3.7m) corresponding to an EBITDA margin of 19.4%. · Net profit was SEK 0.1m compared with the loss in the same period in 2019 (SEK -5.4m). · Basic earnings per share amounted to SEK 0.00  (-0.75). · Cash outflow from operating activities of SEK 7.1m primarily due to normalization of working capital as well as a result of paying the lease amounts to April

Targovax to present at the World Immunotherapy Congress

Oslo, 2 November 2020 – Targovax ASA, today announces that Magnus Jäderberg, CMO of Targovax, will present the company at the World Immunotherapy Congress today, Monday 2 November, at 11:20 CET.The presentation will be available to download at www.targovax.com  after the event.   About the event The World Immunotherapy Congress is part of the Festival of Biologics. The Festival of Biologics is the meeting place for the life science community to bridge the gap between academia and industry.

Veidekke ASA: Signed contract to expand road in Västerås, Sweden

Veidekke has been commissioned by the Swedish Transport Administration to expand a 14.5 km stretch of road in Västerås, Sweden. The project is an execution contract with a contract amount of SEK 206 million. Work starts in January 2021 and is scheduled to be completed in November 2022.To improve safety and navigability, road 56 on the stretch between Kvicksund and Västjädra in Västerås municipality will be expanded into a 2+1 lanes country road. Also included in the contract is new lighting and a noise screen. “We look forward to starting work on the expansion of road 56 and to further

ABAX acquires RAM track-and-trace and enters Belgian market

In June ABAX completed the acquisition of RAM track-and-trace that will result in ABAX expanding their operations into Belgium and further strengthen its position on the Europe telematics market, adding 29.000 vehicle tracking subscriptions to their portfolio.- The acquisition is an important step for us to further strengthen our operations and our position in the Europe. With the acquisition ABAX will enter Belgium and expand out operations in Europe, stated Morten Strand, Group CEO of ABAX.   Joining a global network of 350.000 subscriptions Through the acquisition, RAM

Read original

Real estate companies give Swedbank joint top ranking in customer satisfaction survey

Swedbank has been ranked joint number one in Prospera’s annual customer satisfaction survey, Corporate Banking 2020 Real Estate Sweden.“We are very proud of this joint top ranking in this survey, which is highly influential in the industry. It demonstrates that we are doing the right things and that our clients trust us, says Urban Håkansson, Head of Sector Real Estate & Construction, LC&I, Swedbank. Kantar Sifo Prospera’s annual client and market survey shows that Swedbank is once again in first place. This time the top ranking is joint. Real estate clients assessed Swedbank and other

AddSecure acquires RTL Telematics through its Smart Transport UK company, Connexas

RTL’s strong technical offering of solutions for hazardous goods and advanced vehicle cameras, is of particular importance to AddSecure and will be rolled out across the wider Smart Transport customer base. AddSecure , a leading European provider of premium IoT solutions, with a focus on secure critical communications and data, today announced that it has acquired RTL Telematics  through its Smart Transport UK company, Connexas. The objective is to further strengthen its market leading position within Transport and Logistics in the

Read original

Attana will participate at Stora Aktiedagen digitalt on December 2[nd] to discuss the upcoming rights issue and future plans

Attana will participate at Aktiespararna’s Stora Aktiedagen digitalt to deliver a company presentation and answer questions. It will be a 20-minute presentation followed by a 10-minute Q&A from 09.00 to 09.30 on December 2[nd].The presentation will primarily focus on the upcoming rights issue and the future plans it enables. More information about the presentation and a link to the livestream of the event will be published in an upcoming press release.

Herantis Pharma Announces R&D Update

Herantis Pharma Plc (“Herantis”), an innovative drug development company aiming to revolutionize standard therapeutic approaches with leading biologic and gene therapy, today announced an update on its Research & Development pipeline. Management will host a webcast on the R&D Update at 2:00 p.m. CET on Monday 2nd November 2020. Updates on the CDNF Program: The company has recently reported 6- and 12-month data of an EU funded Phase I/II clinical study with Cerebral Dopaminergic Neurotrophic factor (CDNF) in patients with Parkinson’s Disease (PD). Being a first-in-human study with CDNF,

Sinch AB (publ): Invitation to conference call and web presentation of Sinch Q3 2020 quarterly report

Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH Sinch AB will publish its Q3 2020 quarterly report on Tuesday, November 3, 2020, at 07:30 AM CET. You are invited to participate in a conference call at 14:00 AM CET on the same day. Oscar Werner, CEO, and Roshan Saldanha, CFO, will present the report and review the results. Time for publication of the interim reportTuesday November 3, 2020, at 07:30 AM CET Time for conference call and web presentationTuesday November 3, 2020, at 14:00 AM CET Dial-in numbers and access codePlease make sure you are connected to the phone

Grant of Options subject to shareholder approval – Mandatory notification of options and shareholding

The Board of Directors of Otello Corporation ASA (the "Company") has today granted a total of 3,450,000 options in the Company, representing approximately 2.5% of the current total number of shares issued (the "Options"). The Options are granted subject to subsequent shareholder approval at the next general meeting and at the latest at the ordinary general meeting to be held in 2021. Upon grant of the Options, all previously granted and outstanding options of the grantees as set out below have terminated and have become null and void. If the required shareholder approval is not given, all

Aquaporin Inside® writes industrial history and secures food contact material compliance

Aquaporin has, as the first company ever in industrial history, secured Food Contact Material (FCM) compliance for the Aquaporin Inside® technology – a pioneering technology, which utilizes the power of natural membrane proteins, produced in an industrial process. As part of the FCM compliance process, Aquaporin has received an FCM compliance letter from the U.S. Food and Drug Administration (FDA). This entails that Aquaporin’s proprietary Aquaporin Inside® technology  can be used as food contact material in industrial

There are no items matching the current filter
There are no more items matching the current filter
Back to top